Go back

1 April 2026

Capital Markets

The Analyst
Coverage Desert

Below $300 million in market capitalisation, the median analyst coverage is zero. Not thin. Not sparse. Zero. This is not a temporary gap. It is a structural feature of how the research economy broke, and it has not been repaired.

Read now

33%

Decline in FINRA-registered broker-dealer firms from 2008 to 2024

26%

Estimated microcap valuation discount, near historic lows per Goldman Sachs

Somewhere in the Russell 2000 sits a company generating $18 million in EBITDA, carrying $10 million in net cash, and trading at 2.8x enterprise value. No analyst covers it. No institution owns more than 3% of the float. The stock has not moved in two years. This is not a distressed company. It is an invisible one.

This article examines the structural causes of the analyst coverage desert in small and microcap public equities, its measurable valuation consequences, and why the damage is durable despite recent regulatory reversal.

Analysis draws on SEC staff data, FINRA industry snapshots, Acuitas Investments FactSet data, and Goldman Sachs Asset Management research.

This article examines the structural causes of persistent NAV discount in public equities and sets out why this condition has never been more pronounced than it is today.

The analysis draws on proprietary balance-sheet screening and third-party research from Research Affiliates, Goldman Sachs Asset Management, Pzena Investment Management, and Russell Investments.

Median analyst coverage for companies below $300M market cap

8.4%

Microcap stocks with zero analyst coverage, FactSet / Acuitas June 2025

33%

Decline in FINRA member firms from 2008 to 2024, a fall of over 1,600 firms

26%

Estimated microcap valuation discount on trailing P/E basis, Goldman Sachs 2025

The Size of the Gap

The average S&P 500 company is covered by 19 sell-side analysts. The average Russell 2000 company has six. Below $300 million in market capitalisation, where nearly half of all US-listed companies reside, the median drops to zero.

According to FactSet data compiled by Acuitas Investments as of June 2025, 8.4% of microcap stocks carry no analyst coverage whatsoever. For those that do, the average is three estimates. Large caps, by contrast, are covered by 16 analysts on average, with virtually no gaps in the universe.

The coverage gradient is not incidental. It is structural, the product of three converging forces that systematically eliminated the economics of small-cap research over the past decade.

At the end of 2024, the valuation discount of U.S. small-cap stocks relative to large-cap peers stood at approximately 40%, well below the historical median gap of roughly 5%, and sitting in the bottom 4th percentile since 1990. Global small caps now trade at discounts last seen only during the Nifty Fifty and dot-com eras — extreme episodes defined by irrational concentration at the top of the market.

In the United States, small caps trade at a 26% discount to large-cap peers on a price-to-earnings basis, excluding unprofitable companies, which is close to historic lows. Outside the U.S., international small caps, which have historically traded at a premium to local large caps, have flipped to an 8% discount despite offering higher forward earnings growth.

The numbers that matter most: more than 5,000 public companies globally trade below their intrinsic asset value. U.S. small caps have underperformed large-cap peers by approximately 103% cumulatively over the last decade. The Russell 2500 Value Index price-to-book ratio has fallen to multi-decade lows. And zero repeat acquirers of sub-$300M, below-NAV public companies exist globally. Not few. Zero.

Average Analyst Coverage per Stock

By index tier · Source: FactSet / Acuitas Investments, June 2025

Large Cap

19 analysts

Mid Cap

12 analysts

Small Cap

6 analysts

Micro Cap (<$300M)

0 analysts

How the Desert Formed

The US public market itself has been shrinking for three decades. The number of domestically listed companies peaked at 8,090 in 1996 and had fallen to approximately 4,200 by the early 2020s, a decline of nearly 50% over a period when the US economy more than doubled in size. This is largely a US-specific phenomenon; listings expanded in most other developed markets over the same period. The causes are domestic: Sarbanes-Oxley compliance burdens, the sustained growth of private equity as an alternative to public markets, and the acquisition of potential small-cap listings by large technology platforms. Six technology firms alone acquired over 870 companies since the late 1990s.

The broker-dealer network contracted first and hardest. FINRA data shows the total number of registered member firms fell from 4,896 in 2008 to 3,249 by end of 2024, a decline of 33.6% over sixteen years. The independent research boutiques that historically made small-cap coverage economically viable were gutted in the aftermath of the financial crisis and never rebuilt. The SEC formally acknowledged the consequence in a 2022 staff report to Congress, naming broker-dealer consolidation as a primary driver of deteriorating research coverage for small issuers. Its own data showed that only 60% of small issuers received any research coverage in the 2016-2020 period, versus 90% of large issuers.

Three structural forces have combined to create and entrench this mispricing. The first is the passive investing wave. Passive funds now account for approximately 62% of small-cap fund assets, up from 40% in 2014. Passive strategies cannot discriminate between a fairly priced company and one trading at 30 cents on the dollar of net asset value. Capital flows indiscriminately. The result is a systematic failure to correct prices that are obviously wrong.

The second force is the analyst coverage desert. While large-cap stocks are typically covered by an average of 16.4 sell-side analysts, small caps receive coverage from only about 5.7. For micro-cap companies below $300 million in market capitalisation, coverage thins further still, with nearly one-third covered by a single analyst or none at all. Markets are informationally efficient only where information flows. Where it does not, mispricing can persist indefinitely.

The third force is the M&A gap. Private equity firms in the U.S. alone sit on an estimated $1 trillion in dry powder. Yet that capital is systematically directed toward private businesses or larger public companies where deal economics justify the infrastructure costs of a major transaction. Sub-$300 million public companies fall below the minimum viable deal size for institutional capital. They are not overlooked because they are bad businesses. They are overlooked because the market has no systematic mechanism to unlock their value.

FINRA-Registered Member Firms

2009-2024 · Source: FINRA Industry Snapshots 2022, 2025

4,717 → 3,249

33.6% decline over sixteen years

A $50 billion fund cannot meaningfully own a $150 million company. Analyst hours stopped being allocated to these names not because the companies lacked merit, but because the economics of covering them had evaporated entirely.

Index funds now account for 53% of all long-term US fund assets, up from 31% in 2016. That concentration of AUM into fewer, larger managers created a structural constraint that eliminated the incentive to cover smaller names entirely.

Passive vs. Active -- Share of US Fund Assets

2016-2024 · Source: Morningstar / PWL Capital

MiFID II accelerated an existing trend. When European regulators forced asset managers to pay for research explicitly rather than bundling it into trading commissions in 2018, sell-side desks ran the numbers and dropped coverage of anything where trading volume could not justify the analyst's time. A 2019 CFA Institute survey of nearly 500 investment professionals across 25 countries found that 47% of buy-side and 53% of sell-side respondents reported a direct reduction in small and mid-cap coverage. A University of Toronto study found that 334 European companies lost sell-side coverage entirely, with firms 157% more likely to lose coverage than their North American counterparts over the same period. By 2019, a Peel Hunt and Quoted Companies Alliance survey of 155 UK-based fund managers found that over 80% reported a decrease in small and mid-cap research availability.

The Buy-Side Internalisation Effect

When large asset managers moved research in-house post-MiFID II, that research was produced for their own portfolios, with no incentive to publish or share. The buy-side internalisation of research deepened the information vacuum rather than filling it.

The rise of passive investing, the retreat of sell-side analyst coverage from smaller companies, and the absence of systematic acquirers at the sub-$300M level are all durable features of modern capital markets, not temporary dislocations.

Research Affiliates projects that U.S. small-cap indexes can outperform large-cap peers by 4% annualised over the next decade, driven directly by the extremity of the current discount.

The Regulatory Admission

Regulators have finally conceded what the market had been experiencing for years. The EU Listing Act, which entered into force in December 2024, reversed MiFID II's unbundling requirements, explicitly citing the collapse of small and mid-cap research coverage as the motivation. The UK's FCA followed with its own rebundling rules in mid-2025, acknowledging that the original regulation had led directly to less coverage of smaller and mid-sized companies. The EU attempted a partial fix as early as 2021, allowing bundled research for issuers below 1 billion euros market cap. The decline did not slow down. The Listing Act abolished the threshold entirely.

But regulatory acknowledgment does not translate quickly into recovery. Most brokerages disbanded their research departments after unbundling came in.

Altuva Group is a NASDAQ-listed permanent capital vehicle built to fill this gap. The platform acquires undervalued public companies using Altuva's own publicly traded equity as acquisition currency. This is not a fund with a fixed mandate and a finite timeline. It is a compounding vehicle designed to grow with every transaction.

By acquiring companies trading at 30 to 50 cents on the dollar of NAV using Altuva equity that trades at a meaningful premium to NAV, each deal is immediately accretive to NAV per share. The acquisition currency grows. The platform's capacity to execute the next deal grows with it.

The team brings over 160 years of combined experience in special situations, distressed investing, and complex capital structures, drawn from Oaktree Capital, Elliott Management, Brevan Howard, Cerberus, BlackRock, Macquarie, and Merrill Lynch, with more than $30 billion deployed across special situations globally.

Management teams at these companies have largely stopped engaging with capital markets because capital markets stopped engaging with them. The listing has become administrative. The share price has become a formality.

Annual listing costs, compliance, audit, D&O insurance, investor relations, run $2-5 million for a company doing $10-15 million in EBITDA. That is a meaningful drag on a business whose stock no longer functions as a currency and whose institutional shareholder base has effectively emptied out.

The Valuation Consequences

The gap this creates is measurable. Microcap stocks currently trade at 14.3x earnings versus 26.6x for large caps, according to Acuitas Investments' analysis of FactSet data as of June 2025. Goldman Sachs estimates the discount at 26% on a trailing P/E basis excluding unprofitable companies, near historic lows. Part of this differential reflects genuine differences in business maturity and profitability. The size premium identified by Fama and French in 1992 remains one of the most replicated findings in academic finance. But a meaningful portion of the valuation gap reflects neglect, not fundamentals.

When no analyst covers a company, price discovery stops functioning. Bad news does not get written up. Good news does not either. The stock drifts, disconnected from fundamentals, until a catalyst forces a re-rating that should have happened years earlier. Active managers in microcap continue to generate meaningful excess returns precisely because the information inefficiency is structural and persistent.

There is no way the firm reverses its stance on absorbing research costs after more than five years.

Schroders CEO Peter Harrison · Acuity Knowledge Partners, August 2024

The infrastructure that was dismantled does not rebuild on a legislative timeline. What regulators have effectively done is confirm the thesis: the coverage desert is real, it was policy-driven, and the damage is durable.

Coverage by Index Tier

19

Average analysts per S&P 500 company

6

Average analysts per Russell 2000 company

$30B+

Combined capital deployed by the team across special situations globally

160 yrs

Combined team experience in special situations and distressed investing

Three Forces That Formed the Desert

Broker-dealer network contracted 33.6% from 2008 to 2024, gutting small-cap research boutiques

Passive capital concentration eliminated economic incentive to cover small names
MiFID II unbundling forced sell-side desks to drop low-volume coverage entirely

U.S. small-cap P/E discount to large caps: 26% (ex-unprofitable)

International small-cap discount to local large caps: 8%
Passive funds' share of small-cap assets: 62% (up from 40% in 2014)
Average analyst coverage, large caps: 16.4 analysts
Average analyst coverage, small caps: 5.7 analysts
Micro-caps with one analyst or fewer: approximately one-third
U.S. private equity dry powder: ~$1 trillion

Cost of Remaining Listed

SOX compliance: $500K-$1.5M annually

D&O insurance: $200K-$1M annually
PCAOB audit fees: $300K-$800K annually
IR, legal, SEC filing: $300K-$600K annually
Total for $15M EBITDA company: $2-3M per year

~$90M in annual revenue

$15M in adjusted EBIT
7+ completed acquisitions
15+ global markets
9-year operating track record
Software and digital commerce focus

Regulatory Response

EU Listing Act entered into force December 2024 -- reversed MiFID II unbundling

UK FCA rebundling rules followed in mid-2025
Most sell-side research departments already disbanded -- damage is not easily reversed

Six Conditions That Define
a Coverage Desert Company

What Separates This From Everything Else

Six Conditions That Define
a Coverage Desert Company

Six Conditions That Define a Coverage Desert Company

Not every undercovered company is an opportunity. These six conditions identify the subset where the gap between market price and recoverable value is structural and actionable -- not a reflection of genuine impairment.

Zero or Near-Zero Coverage

No sell-side analyst has published a note in twelve or more months. The company does not appear in consensus estimate databases. Price discovery has effectively stopped functioning, disconnecting the market price from underlying fundamentals.

Sub-$300M Market Cap

Below the threshold of institutional mandate for most active managers and below the capacity threshold for microcap specialists with SEC disclosure obligations triggered at 5% ownership. The company sits in a structural no-man's land where no natural buyer exists.

Observable Balance Sheet Value

Cash, listed securities, real property, or receivables from creditworthy counterparties that can be independently valued. The discount is to identifiable, realizable assets -- not to speculative future cash flows or intangible goodwill.

Fragmented Shareholder Base

No single holder large enough to compel management action. Institutional ownership low or concentrated in passive products with no active engagement mandate. No existing activist position with an articulated realization thesis already in play.

Operational Simplicity

A manageable core business that is generating cash, not burning it. Single-segment, domestically focused operations preferred. Complex multi-geography structures with regulatory dependencies increase execution risk and extend the realization timeline.

Governance Accessibility

No poison pill, no staggered board, and board representation accessible within 90 days of closing. The structural precondition for value realization is control -- without it, the discount persists regardless of how large or how visible it becomes.

Valuation Framework

How the Coverage Desert Creates Persistent Mispricing by Cap Tier

Tier

Analyst Coverage

Institutional Ownership

Valuation Multiple

Opportunity

S&P 500 (Large Cap)

19 analysts average, virtually universal coverage

High -- index funds, active managers, sovereign wealth all present

26.6x earnings -- efficient pricing with minimal information gaps

Efficient

Russell 2000 (Small Cap)

6 analysts average -- declining but still functional

Moderate -- some institutional presence, limited active engagement

Compressed vs. large cap, but still subject to active price discovery

Partial

Sub-$300M (Microcap)

Median zero -- 8.4% carry no coverage at all

Minimal -- below institutional capacity thresholds, passive cannot engage

14.3x earnings vs. 26.6x for large caps -- 26% discount near historic lows

Actionable

Sub-$50M (Nano Cap)

Effectively zero -- SEC data shows 60% receive no coverage at all

Near zero -- most mandates prohibit ownership at this size

Price disconnected from fundamentals -- trading on momentum and noise

Deep Value

Where Altuva
Operates

The coverage desert is not a market failure. It is a structural feature of how the research economics broke, and for those willing to operate within it, it remains one of the most durable sources of mispricing in public equity markets.

The companies sitting in it are not broken. They are ignored. And ignored, at the right price, is the most interesting place to buy.

Altuva was built around a straightforward observation. If the market is not analysing these companies, an investor willing to do the forensic work holds a genuine information advantage. Not through exotic means, but through the basic act of doing what no one else is doing: systematic screening of SEC EDGAR filings, direct engagement with management teams who have not spoken to an institutional investor in years, and fundamental modelling built from scratch rather than inherited from consensus.

The companies Altuva targets are not broken. They are structurally neglected, orphaned by the economics of the research industry, the concentration of passive capital, and the contraction of the broker-dealer network that once connected them to institutional buyers. That neglect creates a valuation gap that active, forensic capital can close.

The coverage desert did not form overnight. The broker-dealer network contracted over sixteen years. The passive capital wave displaced active stock-pickers over a decade. The research infrastructure was dismantled piece by piece. These are structural shifts embedded in how the market now operates, and they are not undone by a change in regulation or a rebound in small-cap indices.

Sources & Footnotes

Jefferies Research / CRSP, University of Chicago Booth School of Business, as cited by Neuberger Berman, "A New Era for Small Caps?" May 2024.
Acuitas Investments, "The Case for Microcap," September 2025, Exhibit 7 (Microcap Analyst Coverage, FactSet data as of 6/30/2025).
Russell Investments, "Is Small Cap Exposure Still a Good Idea?" June 2024. Citing Lattanzio, Megginson & Sanati, "Dissecting the Listing Gap," 2023.
Russell Investments, ibid. Google, Microsoft, Apple, Meta, Amazon and NVIDIA collectively acquired over 870 companies since the late 1990s.
FINRA Industry Snapshot 2022 (Table 2.12, 2008-2021 series) and FINRA Industry Snapshot 2025 (2022-2024). All figures represent total FINRA member firms (broker-dealer only + dual registrant firms), end-of-year totals.
U.S. Securities and Exchange Commission Staff Report, "Issues Affecting the Provision of and Reliance Upon Investment Research Into Small Issuers," February 18, 2022. Mandated by Section 106 of the Consolidated Appropriations Act, 2021.
Morningstar Direct / PWL Capital, "The Passive vs. Active Fund Monitor," year-end 2023 (2016-2023 series); Morningstar US Fund Flows Commentary, December 2024 (2024 data point).
CFA Institute, "MiFID II: One Year On," February 2019. Survey of 496 investment professionals across 449 firms and 25 countries, conducted December 2018.
Fang, Hope, Huang & Moldovan, "The Effects of MiFID II on Sell-Side Analysts, Buy-Side Analysts and Firms" (University of Toronto / City University London / Concordia University), SSRN 3422155, as reported by IR Magazine, July 2019.
Peel Hunt / Quoted Companies Alliance, UK Small and Mid-Cap Research Survey, as reported by IR Impact, February 2020. Survey of 155 UK-based fund managers and 110 small and mid-cap companies.
Acuitas Investments, "The Case for Microcap," September 2025, Exhibit 1 (Characteristics of Microcap vs. Small and Large Cap, FactSet data as of 6/30/2025).
Goldman Sachs Asset Management, "Beyond the Beta: Actively Seeking Small-Cap Alpha," November 2025. Furey Research Partners / FactSet data as of September 30, 2025. Valuation defined by LTM P/E excluding unprofitable companies.
Fama, Eugene F. and French, Kenneth R., "The Cross-Section of Expected Stock Returns," The Journal of Finance, Vol. 47, No. 2, June 1992.
Acuitas Investments, "The Case for Microcap," September 2025, Exhibit 2 (Percentage of Fama-French Deciles Within Each Russell Index, as of 6/30/2025). Kenneth French data library / FTSE Russell / FactSet.
Acuitas Investments, ibid. Exhibit 3 (Annualized Monthly Returns of Simulated Indexes Ending 6/30/2025). Simulated microcap index constructed using Fama-French decile weights aligned to Russell Microcap Index composition.
Acuitas Investments, ibid. Exhibit 6 (Annualized Active Manager Excess Returns through 6/30/2025). Source: eVestment universe data, gross of management fees.
Acuitas Investments, ibid. Product capacity estimates based on standard microcap manager portfolio construction (60-100 stocks). SEC filing requirement triggered at >5% ownership per company.
Stibbe, "Listing Act: Reversing MiFID II's Unbundling Regime, Is It Enough?" May 28, 2025. EU Listing Act (Directive 2024/2811) entered into force December 4, 2024. Member States required to implement by June 5, 2026.
Acuity Knowledge Partners, "MiFID II Rollback: Exploring Opportunities in the New Regulatory Landscape," August 2024. Schroders CEO Peter Harrison quoted directly.

What is your company's
true value?

A 30-minute call is all it takes.

Book an introductory call

Strictly confidential

No obligation

No
obligation

No public disclosure

No disruption to operations

Strictly confidential

No public disclosure

No obligation

No disruption to operations

Altuva Group

5,271

The AnalystCoverage Desert

The AnalystCoverage Desert

The AnalystCoverage Desert

The AnalystCoverage Desert

The AnalystCoverage Desert

The Size of the Gap

The Size of the Gap

The Size of the Gap

How the Desert Formed

How the Desert Formed

How the Desert Formed

The Regulatory Admission

The Regulatory Admission

The Regulatory Admission

The Valuation Consequences

The Valuation Consequences

The Valuation Consequences

19

6

$30B+

160 yrs

Strictly confidential

No obligation

No obligation

No public disclosure

No disruption to operations

Strictly confidential

No public disclosure

No obligation

No disruption to operations

The Analyst
Coverage Desert

The Analyst
Coverage Desert

The Analyst
Coverage Desert

The Analyst
Coverage Desert

The Analyst
Coverage Desert

No
obligation